Clinical Trial Update: Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial evaluated Zonegran (zonisamide) for weight gain associated with psychotropic medications; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Tuscaloosa Research & Education Advancement Corporation | Conditions: Obesity | Phase 4 | Status: COMPLETED